학술논문

A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer.
Document Type
Article
Source
Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p387-387, 1p
Subject
Language
ISSN
0732183X